Tower Research Capital LLC (TRC) - PASITHEA THERAPEUTICS CORP ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of PASITHEA THERAPEUTICS CORP
ValueSharesWeighting
Q3 2023$5,995
-2.0%
12,490
+0.0%
0.00%
Q2 2023$6,120
+122300.0%
12,489
-0.9%
0.00%
Q1 2023$5
-50.0%
12,601
-16.3%
0.00%
Q4 2022$10
-99.9%
15,049
+165.9%
0.00%
Q3 2022$7,000
+250.0%
5,659
+151.1%
0.00%
Q2 2022$2,000
-96.2%
2,254
-92.3%
0.00%
-100.0%
Q4 2021$52,000
+766.7%
29,385
+1502.2%
0.00%
Q3 2021$6,0001,8340.00%
Other shareholders
PASITHEA THERAPEUTICS CORP shareholders Q4 2023
NameSharesValueWeighting ↓
NAPLES GLOBAL ADVISORS, LLC 10,620$5,0950.00%
XTX Topco Ltd 10,726$5,1450.00%
MARK SHEPTOFF FINANCIAL PLANNING, LLC 3,323$1,5940.00%
Virtu Financial LLC 15,469$70.00%
ROYAL BANK OF CANADA 5,000$2,0000.00%
UBS Group AG 83$400.00%
WELLS FARGO & COMPANY/MN 151$720.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 125,123$60,0560.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 38,568$18,5010.00%
View complete list of PASITHEA THERAPEUTICS CORP shareholders